anonymous
Guest
anonymous
Guest
I hope you are right and I hope you have plans in place in case I am right.
Give it a rest. Different year/month/day/hour/minute/second and same garbage being spewed from negative nellie mouths on here. Same rumors constantly swirling. Accurately predicted about 1 out of 100 times.
Start with the treacherous suck up VKCL near Detroit, Michigan. He barely calls on anybody and has the reps do his work for him.
S. Swider is the biggest slimeball sycophant in the Vaccine Division. The little red adulator to management will stop at nothing to get ahead in Merck. He will come up with grand ideas as a VKCL then make the reps do all of the hard work, then he will take all of the credit. He will piggyback off any success someone has and make it his own. God forbid you don't help him in his quest for power. He will throw you under the bus in heartbeat. Stay away from him. He is a toxic little red rattlesnake.
Wow. He seems like such a savvy businessman.
Wow. He seems like such a savvy businessman.
What part of Zostavax has been promoted for 10 years and it still hasn't made any traction don't you understand? Every other product in our portfolio eventually became successful after a couple of years, including Adult hep A and Adult hep B, with the exception of Zostavax. What makes Zostavax unique? It has the worse efficacy profile in the portfolio and reimbursement isn't great either.
Pneumovax 23? That vaccine sold it self for 30 years until P13 got the adult indication and Merck was slow to react. How is a Pneumo Vaccine with 13 valents doing better than one that has been around over 30 years with 23 valents? Reimbursement! Pfizer did its homework and new reimbursement would be key. Merck leadership did a horrible job with reimbursement (Zostavax and P23) and also fumbled on the supply issue for Zostavax when it first came out. Also, why didn't Merck fight like hell to get Zosta on the funded Medicare Part B program rather than the unfunded Medicare part D? You can't blame the field for those blunders. Leadership botched both adult Vaccine opportunities and no marketing messages or nag based selling model will fix it. Period.
Pulling the pharmacy vaccine division to have them call on Zosta non-users along with a contract salesforce is an act of desperation by Jan Nissan to save her job. If we don't get the hexavalent vaccine or our version of Prevnar approved for Pediatrics approved, layoffs will come soon. So once again, pediatric Vaccines may save us.
Jan will be gone and the DCO on Southern CA will take over as she is being groomed for that position.
Due tell, due tell.....I wish, but it is still a cash cow...Vaccine division will be gone next year.
Would she even be any better than Jan? SHE is just learning the Vaccines World now...but ant could be better... Except for another crazy marketing penn partner....Jan will be gone and the DCO on Southern CA will take over as she is being groomed for that position.
Would she even be any better than Jan? SHE is just learning the Vaccines World now...but ant could be better... Except for another crazy marketing penn partner....![]()
Must be from AR or MS, can't spell ..Would she even be any better than Jan? SHE is just learning the Vaccines World now...but ant could be better... Except for another crazy marketing penn partner....![]()
Would she even be any better than Jan? SHE is just learning the Vaccines World now...but ant could be better... Except for another crazy marketing penn partner....![]()
SS is a snake and that was well-known even when he was an analyst at HQs. The DCOs are idiots and are blinded by the ass kissing to see through the likes of him.
Tom Lyon really thinks he is the smartest person in the room but he is so gullible when it comes to knowing what his VKCL's are doing in the field. Ever since the type A control freaks who came over to Vaccines like Alina, Tom Lyon and Katrina Murphy to name of few of those out of touch managers, who cannot separate a personal life from a job, the division has suffered a decline in success with customers and morale.
Healthcare providers used to really love their Vaccine reps before these head cases in management arrived because the reps were allowed to act like calm human beings who were there to educate, promote and support Vaccines in a personable way based on the personality of the reps. Once those tablet corporate psychopaths came, they turned the reps into robotic, desperate and pushy zombies that healthcare providers cringe when they see them because now they are coming way to frequently because of the reach and frequency drive as well as the same desperate strategy to shame the customer into buying more vaccines. The combination of reach and frequency and the desperate hope that Merck could get primary care offices to vaccinate like pediatricians has failed going on a decade now. Merck has gotten the most it is ever going to get out of Zostavax and P23 because of competition and better reimbursement (I guarantee you GSK will provide better reimbursement for their Shingles vaccine just like Pfizer did for P13). Jan's last desperate attempt to push R&F and send different groups of full-time and contract reps to call on any primary care doc or pharmacy to use Zostavax has led to double digit negative growth.
I know this management team will never admit they are wrong. However, maybe they should abandon the R&F strategy because it blocked access to docs and integrated delivery systems in the early 2000's that still hurt today. Also, instead of blaming the reps all of the time for the decline in adult Vaccines which is happening consistently across the nation, maybe you should just admit you miscalculated the potential demand for adult Vaccines which we know won't happen. Instead, Jan will be put on a special project and another old school tablet upper manager will come in with the more role play and more R&F will save the day mantra. This has been the Groundhog Day from Hell ever since the Tablet Takeover of 2005.